The injectable peptide is given daily over a short time period
Silvio Inzucchi, MD Qualification: Professor of Medicine, Yale University Metformin, primarily used for type 2 diabetes management, helps with weight loss by improving insulin sensitivity and reducing fat storage
however, after the appearance of prospective randomized studies that indicated an increase in the incidence of breast cancer, the establishment of this therapy has been adjusted to the presence of certain risk factors, symptoms, and the evolution of patients (Zhao and Brinton, 2006)

Semaglutide vs Tirzepatide: Key Differences at a Glance While both medications are highly effective, their differences can matter when tailoring treatment: Mechanism of action Semaglutide: GLP-1 receptor agonist Tirzepatide: Dual GLP-1 + GIP receptor agonist Average weight loss Semaglutide: Significant and consistent weight reduction Tirzepatide: Often produces greater total weight loss in clinical trials Metabolic effects Semaglutide: Strong appetite control and satiety Tirzepatide: Appetite control plus enhanced metabolic and insulin effects Side effect profile Both: Most commonly include nausea, constipation, diarrhea, or reflux, typically during dose escalation Neither option is better universally tolerability varies by individual How Do You Choose the Right GLP-1 for Weight Loss